METABOLIC AREA
SESSION 1
Early Indicators and Long-Term Outcomes in Metabolic Health
- Chairperson: Prof. A. Echtay
Opening and Introduction
Metabolic Memory: The Impact of Early Glycemic Control on Long-Term Health
Prof. A. Esteghamati
Dr. N. Jarrah
Dr. Q. Al-Zajaji
Prof. A. Echtay
This interactive round table discussion explores how early glycemic control creates a lasting legacy on long-term outcomes. Experts will revisit landmark trials to highlight the sustained benefits of early intervention on complications and prognosis. The discussion will also address the role of metformin in early type 2 diabetes management and its contribution to durable glycemic control.
Prediabetes Management: Lifestyle with or without Pharmacologic Interventions
Dr. G. Altaai
This session explores the evolving landscape of prediabetes management. Through insights from key clinical trials and real-world experiences, it will highlight the benefits and limitations of lifestyle intervention alone versus the addition of pharmacologic therapy such as metformin. live audience polling will spark reflection and reveal practice patterns
SESSION 2
Optimizing Diabetes and Hypothyroidism Management
- Chairperson: Dr. A.K. Nikousokhan Tayar
Metformin Beyond Glycemic Control: Cardiovascular Protective Effects
Prof. R. Ferrari
Beyond its glucose-lowering effect, metformin may offer cardiovascular benefits. This talk explores
emerging evidence that challenges the traditional view of metformin as solely an antidiabetic agent,
highlighting its potential role in broader cardio-metabolic risk reduction.
Hypothyroidism: The Missing Piece in the Puzzle
Prof. S. Razvi
Hypothyroidism often hides in plain sight, presenting through vague symptoms or blending into existing comorbidities. This session explores how thyroid dysfunction may be an overlooked
contributor in various patient profiles, emphasizing the importance of timely screening and considering hypothyroidism, when the clinical picture remains incomplete.
The Interplay Between Type 2 Diabetes and Hypothyroidism
Dr H.r Al Alidrisi
This session highlights the overlooked yet clinically significant relationship between type 2 diabetes and hypothyroidism. Through a real patient case, attendees will explore how these two conditions can influence each other’s course, the diagnostic challenges that arise, and why routine screening for thyroid dysfunction in patients with T2DM is a crucial step toward optimal disease management.
Expert Panel Discussion
SESSION 3
Tailoring Treatment in Diabetes and Thyroid Disease
- Chairperson: Dr. G.T. Moleele
Hypothyroidism in Women's Health: Challenges and Solutions
Prof. S. Razvi
This session explores the impact of hypothyroidism on women’s health. Especially the higher
vulnerability of women to the adverse effects of hypothyroidism, spanning reproductive age, pregnancy, and the menopausal transition. It addresses the often subtle and overlooked symptoms, the risk of delayed diagnosis, and the impact on women’s health, and maternal outcomes.
Persistent TSH Elevation: Patient, Medication, or Underlying Factors?
Dr. S. V. Yousefi
This presentation explores the refractory hypothyroidism and multifactorial reasons behind persistent TSH elevation despite treatment. It examines key contributors such as patient adherence, drug formulation, gastrointestinal absorption issues, and other often-overlooked clinical factors.
Dual Mechanisms in Advanced Diabetes: The Role of Glucovance
Dr. N. Jarrah
Glucovance combines metformin and glibenclamide, targeting both insulin resistance and insulin deficiency. This presentation revisits its relevance in advanced cases, particularly where glycemic control remains suboptimal on monotherapy.
Expert Panel Discussion
Closing